Literature DB >> 25504061

The effect of chronic peripheral nesfatin-1 application on blood pressure in normal and chronic restraint stressed rats: related with circulating level of blood pressure regulators.

Ceylan Ayada1, Günfer Turgut, Sebahat Turgut, Zuhal Güçlü.   

Abstract

Nesfatin is a peptide secreted by peripheral tissues, central and peripheral nervous system. It is involved in the regulation of homeostasis. Although the effects of nesfatin-1 on nutrition have been studied widely in the literature, the mechanisms of nesfatin-1 action and also relations with other physiological parameters are still not clarified well. We aimed to investigate the effect of peripheral chronic nesfatin-1 application on blood pressure regulation in normal and in rats exposed to restraint immobilization stress. In our study, three month-old male Wistar rats were used. Rats were divided into 4 groups as Control, Stress, Control+Nesfatin-1, Nesfatin-1+Stress. Angiotensinogen, angiotensin converting enzyme 2, angiotensin II, endothelin-1, endothelial nitric oxide synthase, aldosterone, cortisol, nesfatin-1 levels were determined in plasma samples by ELISA. Our results have shown that chronic peripheral nesfatin-1 administration increases blood pressure in normal and in rats exposed to chronic restraint stress. Effect of nesfatin-1 on circulating level of angiotensinogen, angiotensin converting enzyme 2, angiotensin II, endothelin-1, endothelial nitric oxide synthase, aldosterone and cortisol has been identified. We can conclude that elevated high blood pressure after chronic peripheral nesfatin-1 administration in rats exposed to chronic restraint stress may be related to decreased plasma level of endothelial nitric oxide synthase concentration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25504061     DOI: 10.4149/gpb_2014032

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  8 in total

Review 1.  Nesfatin-1 and its effects on different systems.

Authors:  C Ayada; Ü Toru; Y Korkut
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

2.  Expression and function of nesfatin-1 are altered by stage of the estrous cycle.

Authors:  Alicia T Pate; Abigayle L Schnell; Teresa A Ennis; Willis K Samson; Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-29       Impact factor: 3.619

3.  Balanced oxidative status by nesfatin-1 in intestinal ischemia-reperfusion.

Authors:  Ceylan Ayada; Ümran Toru; Osman Genç; Raziye Akcılar; Server Şahin
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  The Relationship between Nesfatin-1 Levels and SYNTAX Score in Patients with Non-ST Segment Elevation Myocardial Infarction.

Authors:  Mevlüt Serdar Kuyumcu; Aliye Kuyumcu; Çağrı Yayla; Mustafa Bilal Özbay; Sefa Ünal; Burak Açar; Cemil Nural; Almila Şenat; Gülhan Samur
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

Review 5.  DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs.

Authors:  Jianqiang Zhang; Qiuyue Chen; Jixin Zhong; Chaohong Liu; Bing Zheng; Quan Gong
Journal:  Front Immunol       Date:  2019-05-09       Impact factor: 7.561

6.  Nesfatin-1 suppresses peripheral arterial remodeling without elevating blood pressure in mice.

Authors:  Yusaku Mori; Hiroyuki Shimizu; Hideki Kushima; Tomomi Saito; Munenori Hiromura; Michishige Terasaki; Masakazu Koshibu; Hirokazu Ohtaki; Tsutomu Hirano
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

7.  Can Nesfatin-1 Predict Hypertension in Obese Children?

Authors:  Hatice Güneş; Filiz Alkan Baylan; Hakan Güneş; Fatih Temiz
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-07-24

Review 8.  Current Understanding of the Role of Nesfatin-1.

Authors:  Martha A Schalla; Andreas Stengel
Journal:  J Endocr Soc       Date:  2018-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.